Literature DB >> 11137655

Disorders of membrane channels or channelopathies.

G G Celesia1.   

Abstract

OBJECTIVE: To review the structure and function of membrane ion channels with special emphasis on inherited nervous system channel disorders or channelopathies.
RESULTS: Channels are pores in the cell membrane. Through these pores ions flow across the membrane and depolarize or hyperpolarize the cell. Channels can be classified into 3 types: non-gated, directly gated and second messenger gated channels. Among the important directly gated channels are voltage gated (Na(+), K(+), Ca(2+), Cl(-)) and ligand gated (ACh, Glutamate, GABA, Glycine) channels. Channels are macromolecular protein complexes within the lipid membrane. They are divided into distinct protein units called subunits. Each subunit has a specific function and is encoded by a different gene. The following inherited channelopathies are described. (1) Sodium channelopathies: familial generalized epilepsy with febrile seizures plus, hyperkalemic periodic paralysis, paramyotonias, hypokalemic periodic paralysis; (2) potassium channelopathies: benign infantile epilepsy, episodic ataxia type 1; (3) calcium channelopathies: episodic ataxia type 2, spinocerebellar ataxia type 6, familial hemiplegic migraine, hypokalemic periodic paralysis, central core disease, malignant hyperthermia syndrome, congenital stationary night blindness; (4) chloride channelopathies: myotonia congenitas; (5) ACh receptor channelopathies: autosomal dominant frontal lobe nocturnal epilepsy, congenital myasthenic syndromes; (6) glycine receptor channelopathies: hyperekplexia.
CONCLUSIONS: Studies of human inherited channelopathies have clarified the functions of many ion channels. More than one gene may regulate a function in a channel, thus different genetic mutations may manifest with the same disorder. The complex picture of the genetic and molecular structures of channels will require frequent updates.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11137655     DOI: 10.1016/s1388-2457(00)00496-x

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  10 in total

1.  Chronic deficit in the expression of voltage-gated potassium channel Kv3.4 subunit in the hippocampus of pilocarpine-treated epileptic rats.

Authors:  Luis F Pacheco Otalora; Frank Skinner; Mauro S Oliveira; Bianca Farrell; Massoud F Arshadmansab; Tarun Pandari; Ileana Garcia; Leslie Robles; Gerardo Rosas; Carlos F Mello; Boris S Ermolinsky; Emilio R Garrido-Sanabria
Journal:  Brain Res       Date:  2010-10-21       Impact factor: 3.252

2.  Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia.

Authors:  Wan-Jin Chen; Yu Lin; Zhi-Qi Xiong; Wei Wei; Wang Ni; Guo-He Tan; Shun-Ling Guo; Jin He; Ya-Fang Chen; Qi-Jie Zhang; Hong-Fu Li; Yi Lin; Shen-Xing Murong; Jianfeng Xu; Ning Wang; Zhi-Ying Wu
Journal:  Nat Genet       Date:  2011-11-20       Impact factor: 38.330

3.  Reactions of the immune system in epilepsy.

Authors:  Inimioara Mihaela Cojocaru; Manole Cojocaru
Journal:  Maedica (Buchar)       Date:  2010-07

4.  Localization and mutation detection for paroxysmal kinesigenic choreoathetosis.

Authors:  Te Du; Bin Feng; Xin Wang; Wei Mao; Xilin Zhu; Liping Li; Bei Sun; Nifang Niu; Yang Liu; Yuping Wang; Biao Chen; Xingqiu Cai; Ying Liu
Journal:  J Mol Neurosci       Date:  2007-10-19       Impact factor: 3.444

5.  Down-regulation of BK channel expression in the pilocarpine model of temporal lobe epilepsy.

Authors:  Luis F Pacheco Otalora; Eder F Hernandez; Massoud F Arshadmansab; Sebastian Francisco; Michael Willis; Boris Ermolinsky; Masoud Zarei; Hans-Guenther Knaus; Emilio R Garrido-Sanabria
Journal:  Brain Res       Date:  2008-01-18       Impact factor: 3.252

6.  The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents.

Authors:  J-M Rigo; G Hans; L Nguyen; V Rocher; S Belachew; B Malgrange; P Leprince; G Moonen; I Selak; A Matagne; H Klitgaard
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

7.  Gambierol, a toxin produced by the dinoflagellate Gambierdiscus toxicus, is a potent blocker of voltage-gated potassium channels.

Authors:  Eva Cuypers; Yousra Abdel-Mottaleb; Ivan Kopljar; Jon D Rainier; Adam L Raes; Dirk J Snyders; Jan Tytgat
Journal:  Toxicon       Date:  2008-01-12       Impact factor: 3.033

Review 8.  A Molecular Approach to Epilepsy Management: from Current Therapeutic Methods to Preconditioning Efforts.

Authors:  Elham Amini; Mohsen Rezaei; Norlinah Mohamed Ibrahim; Mojtaba Golpich; Rasoul Ghasemi; Zahurin Mohamed; Azman Ali Raymond; Leila Dargahi; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2014-09-09       Impact factor: 5.590

9.  Hyperekplexia (startle disease): a novel mutation (S270T) in the M2 domain of the GLRA1 gene and a molecular review of the disorder.

Authors:  Pablo Lapunzina; Juan M Sánchez; Marta Cabrera; Ana Moreno; Alicia Delicado; Maria L de Torres; Angeles M Mori; José Quero; Isidora Lopez Pajares
Journal:  Mol Diagn       Date:  2003

10.  Brain structural connectome in relation to PRRT2 mutations in paroxysmal kinesigenic dyskinesia.

Authors:  Lei Li; Du Lei; Xueling Suo; Xiuli Li; Chen Yang; Tianhua Yang; Jiechuan Ren; Guangxiang Chen; Dong Zhou; Graham J Kemp; Qiyong Gong
Journal:  Hum Brain Mapp       Date:  2020-06-27       Impact factor: 5.038

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.